TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 SEK)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover |
31,741,662
|
25,728,161
|
24,015,060 |
Financial expenses |
37,403
|
217,450
|
10,135 |
Earnings before taxes |
5,693,016
|
4,839,136
|
3,947,744 |
EBITDA |
7,246,421
|
6,497,511
|
5,221,177 |
Total assets |
47,108,542
|
39,708,996
|
34,249,815 |
Current assets |
33,692,804
|
27,827,217
|
24,136,575 |
Current liabilities |
4,440,123
|
4,006,545
|
3,105,044 |
Equity capital |
40,274,418
|
33,739,488
|
29,216,962 |
- share capital |
1,335
|
1,230
|
1,003 |
Employees (average) |
9,734
|
8,336
|
8,141 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency |
85.5%
|
85.0%
|
85.3% |
Turnover per employee |
3,261
|
3,086
|
2,950 |
Profit as a percentage of turnover |
17.9%
|
18.8%
|
16.4% |
Return on assets (ROA) |
12.2%
|
12.7%
|
11.6% |
Current ratio |
758.8%
|
694.5%
|
777.3% |
Return on equity (ROE) |
14.1%
|
14.3%
|
13.5% |
Change turnover |
6,013,501
|
1,713,101
|
884,905 |
Change turnover % |
23%
|
7%
|
4% |
Chg. No. of employees |
1,398
|
195
|
233 |
Chg. No. of employees % |
17%
|
2%
|
3% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.